RSS
Topas Therapeutics
Multi-year collaborative agreement signed for virus-based therapies
Hamburg-based private platform company, Topas Therapeutics, has signed a multi-year agreement with Boehringer Ingelheim to collaborate in the field of antigen-specific tolerance induction. Read more
Topas Therapeutics will be translational partner for CRC focused on liver inflammation
Topas Therapeutics, a German-based platform company, will serve as the exclusive translational partner for the recently extended Collaborative Research Center (CRC) 841, ‘Liver inflammation: infection, immune regulation and consequences’. Read more
